Menu
Your Cart

Cefotax 500mg IM/IV Injection — Cefotaxime 500mg by Beximco Pharmaceuticals

Cefotax 500mg IM/IV Injection — Cefotaxime 500mg by Beximco Pharmaceuticals
Out Of Stock
Cefotax 500mg IM/IV Injection — Cefotaxime 500mg by Beximco Pharmaceuticals
Tk100.00
  • Stock: Out Of Stock
  • Brand: Renata
  • Product ID: Cefotaxime
0 Pcs sold
5060 Interested

Available Options

This Item is for pre order

Estimated Delivery in

Cefotax 500mg IM/IV Injection — Cefotaxime 500mg | Beximco Pharmaceuticals

Generic NameCefotaxime Sodium 500 mg
Dosage FormPowder for Injection (IM/IV)
Drug ClassThird-Generation Cephalosporin (Beta-lactam Antibiotic)
ManufacturerBeximco Pharmaceuticals Ltd.
Prescription StatusPrescription Only — Hospital / Clinical Use
RouteIntramuscular (IM) or Intravenous (IV)

Overview

Cefotax 500mg contains Cefotaxime Sodium 500mg — a third-generation cephalosporin with broad-spectrum bactericidal activity against Gram-positive and Gram-negative bacteria. Cefotaxime provides excellent tissue penetration including the blood-brain barrier, making it a first-line choice for bacterial meningitis and serious systemic infections. The 500mg strength is used for moderate infections in adults and weight-appropriate dosing in children. It is particularly important in diabetic patients with severe skin, urinary tract, respiratory, or foot infections requiring parenteral antibiotic therapy.

Indications

  • Pneumonia — community-acquired and hospital-acquired
  • Bacterial meningitis — Gram-negative and streptococcal
  • Septicaemia / bacteraemia
  • Complicated UTI and pyelonephritis
  • Intra-abdominal infections (with metronidazole)
  • Diabetic foot infections — moderate to severe with Gram-negative involvement
  • Neonatal sepsis and paediatric severe infections

Dosage

IndicationAdult DoseFrequency
Moderate infections1 g IV/IMEvery 8–12 hours
Severe / meningitis2 g IVEvery 4–6 hours
Gonorrhoea500 mg IMSingle dose
Paediatric (<50 kg)50–200 mg/kg/day dividedEvery 6–8 hours

Reconstitute with sterile water per hospital protocol. IV over 3–5 minutes or infusion over 20–60 minutes. Reduce dose in renal impairment (CrCl <20 mL/min). Always take wound/blood cultures before starting antibiotics.

Diabetic Patient Notes

  • Infection causes profound hyperglycaemia — intensive glucose monitoring and IV insulin infusion standard during hospitalisation
  • Check eGFR — dose reduction required in diabetic nephropathy
  • Polymicrobial diabetic foot infections may require additional agents (metronidazole for anaerobes, anti-MRSA agent if MRSA suspected)

Side Effects and Contraindications

Injection site reactions, GI upset, and hypersensitivity reactions (rash) are most common. Anaphylaxis is rare (~1–2% cross-reactivity with penicillin allergy). C. difficile colitis uncommon. Contraindicated in cephalosporin hypersensitivity. Use with caution in severe penicillin allergy.

Storage

Store below 25°C, protected from light. Use reconstituted solution within 6 hours at room temperature or 24 hours refrigerated.


Medical Disclaimer: For educational purposes only. Injectable antibiotic — hospital/clinical use only. Diabetic patients with severe infection require emergency medical care. Prescription required.

Write a review

Note: HTML is not translated!
Bad Good